Israel Medical Device Registration & AMAR Approval Consulting
Navigate the complexities of the Israeli medical device regulatory landscape with confidence. NexorTest Technologies provides end-to-end AMAR registration support, Israeli Authorized Representative services, and strategic consulting to bring your medical devices to market in Israel efficiently and compliantly.
AMAR Regulatory Authority
Israel Ministry of Health oversees medical device approvals through the Administration of Medical Devices, Accessories & Radiation Equipment.
Abbreviated Pathway Available
Devices with existing CE Marking or FDA clearance benefit from a streamlined review process, significantly reducing time to market.
EU-Aligned Classification
Israel uses a four-class risk-based system (A through D) aligned with the European Union model for device categorization.
Our Israel MedTech Services
NexorTest delivers comprehensive regulatory consulting services tailored to every stage of the Israeli medical device registration process, from initial device classification through post-market compliance.
AMAR Registration Support
Full-service support for submitting your medical device registration application to AMAR. We prepare your complete technical file, manage the submission process, handle all AMAR correspondence, respond to reviewer queries, and shepherd your application through to approval. Our team ensures documentation meets current AMAR requirements including clinical evaluation reports, risk management files, and essential performance data for your specific device classification.
Israeli Authorized Representative Services
Foreign manufacturers are required to appoint an Israeli Authorized Representative before submitting any application to AMAR. NexorTest provides qualified AR services through our established local network in Israel. Your designated representative handles all regulatory communications, manages import license renewals, facilitates vigilance and incident reporting, and ensures your company maintains ongoing compliance with all Israeli regulatory obligations throughout the product lifecycle.
CE/FDA Reference Pathway
Leverage your existing CE Marking or FDA 510(k) clearance to accelerate the Israeli registration process. We specialize in the abbreviated pathway, which allows AMAR to recognize prior regulatory approvals from trusted reference authorities. Our consultants analyze your existing approval documentation, identify any supplementary requirements specific to Israel, prepare the abbreviated submission package, and optimize the timeline to achieve the fastest possible market entry.
Import License Support
Every medical device entering Israel requires a valid import license issued by AMAR. NexorTest manages the entire import license procurement process, including preparation of import documentation, coordination with Israeli customs authorities, license renewal management, and resolution of any import-related regulatory issues. We ensure your supply chain remains uninterrupted by proactively managing license validity periods and renewal deadlines before they impact your operations.
Hebrew Labeling Compliance
Israel mandates that all medical device labeling, instructions for use, and user-facing documentation be provided in Hebrew. NexorTest coordinates professional medical translation services with native Hebrew-speaking regulatory experts who understand both linguistic nuance and MedTech terminology. We review all translated materials for regulatory accuracy, ensure compliance with AMAR labeling format requirements, and verify that safety warnings and contraindications are communicated clearly and correctly.
Post-Market Surveillance
Maintaining AMAR compliance extends well beyond initial registration. NexorTest supports your ongoing post-market surveillance obligations including adverse event reporting, periodic safety update reports, field safety corrective actions, and vigilance system management. We help you establish robust PMS procedures that satisfy AMAR requirements, monitor device performance in the Israeli market, and ensure timely reporting of any safety-relevant incidents to the regulatory authority.
Israel Device Classification System
AMAR uses a four-tier risk-based classification framework aligned with the European Union model. Understanding your device class determines the regulatory pathway, documentation requirements, and expected approval timeline.
| Class | Risk Level | Examples | Review Type | Abbreviated Timeline | Full Review Timeline |
|---|---|---|---|---|---|
| Class A | Low Risk | Non-sterile bandages, tongue depressors, reusable surgical instruments, hospital beds, manual wheelchairs | Self-declaration with notification | 1 – 3 months | 6 – 10 months |
| Class B | Low-Medium Risk | Powered diagnostic equipment, hypodermic needles, hearing aids, infusion pumps, dental filling materials | AMAR technical review | 2 – 4 months | 8 – 14 months |
| Class C | Medium-High Risk | Ventilators, hemodialysis equipment, absorbable sutures, bone fixation plates, infusion pumps with software | Detailed AMAR review with clinical data | 3 – 6 months | 12 – 18 months |
| Class D | High Risk | Heart valves, coronary stents, spinal implants, total joint replacements, implantable defibrillators | Comprehensive AMAR review with full clinical evidence | 4 – 8 months | 18+ months |
Israel Medical Device Registration Process
AMAR offers two registration pathways: the Abbreviated Pathway for devices holding CE or FDA approval, and the Full Review Pathway for novel devices or those without reference authority clearance. Below is a comprehensive overview of both routes.
Abbreviated Pathway (With CE/FDA Reference Approval)
Appoint Israeli Authorized Representative
Engage a qualified Israeli AR who will serve as your legal representative before AMAR. The AR must be established in Israel and authorized to act on the manufacturer’s behalf for all regulatory matters, correspondence, and license management.
Device Classification & Gap Analysis
Determine your device’s AMAR classification (A through D) using the Israeli risk-based rules aligned with the EU system. Conduct a gap analysis comparing your existing CE or FDA documentation against AMAR-specific requirements to identify any supplementary materials needed.
Prepare Abbreviated Technical File
Compile the abbreviated submission dossier including your valid CE certificate or FDA clearance letter, Declaration of Conformity, ISO 13485 certificate, summary of safety and clinical performance, risk management file per ISO 14971, and a Free Sale Certificate from your home country.
Hebrew Labeling & IFU Translation
Translate all device labeling, instructions for use, patient information leaflets, and safety warnings into Hebrew. Translations must be completed by qualified translators and reviewed for regulatory accuracy and compliance with AMAR formatting requirements.
Submit Application to AMAR
Submit the complete registration application through the AMAR digital portal or via your authorized representative. AMAR verifies the completeness of the submission, validates the reference approval documentation, and may request additional clarification or supplementary data.
AMAR Review & Import License Issuance
AMAR conducts its abbreviated review, leveraging the existing CE or FDA evaluation. Upon successful review, AMAR issues the medical device registration certificate and the corresponding import license, authorizing commercial distribution in Israel.
Full Review Pathway (Without Reference Approval)
Appoint Israeli AR & Pre-Submission Meeting
Engage your Israeli Authorized Representative and request a pre-submission meeting with AMAR. This meeting allows you to discuss classification, intended use, and specific documentation expectations with the regulatory reviewers before investing in the full submission package.
Complete Device Classification
AMAR classifies the device based on intended purpose, duration of use, invasiveness, and risk profile using rules aligned with the EU classification framework. The assigned class determines the depth of technical review and clinical evidence required.
Prepare Full Technical Documentation
Assemble a comprehensive technical dossier including device description, design and manufacturing specifications, biocompatibility testing, electrical safety and EMC reports, software validation (where applicable), sterilization validation, shelf-life studies, ISO 14971 risk management file, and complete clinical evaluation with supporting clinical investigation data.
Clinical Evidence Compilation
Prepare the clinical evidence package to satisfy AMAR requirements. This may include a systematic literature review, clinical investigation reports, equivalence assessments, post-market clinical follow-up plans, and any other clinical data demonstrating the device’s safety and performance for its intended use in the Israeli patient population.
Full AMAR Submission & Review
Submit the complete dossier to AMAR for thorough review. The review cycle may involve multiple rounds of questions and requests for additional data. NexorTest manages all reviewer interactions, coordinates timely responses, and tracks the review milestones to keep your submission progressing toward approval.
Approval, Import License & Market Launch
Upon successful completion of the full review, AMAR issues the registration certificate and import license. Establish your post-market surveillance systems, vigilance reporting procedures, and supply chain logistics to begin commercial distribution in the Israeli market.
Why Choose NexorTest for Israel MedTech
NexorTest combines deep regulatory expertise with local Israeli market knowledge to deliver registration outcomes that are faster, more predictable, and fully compliant.
Established Israeli Regulatory Network
Our local team in Israel maintains direct working relationships with AMAR officials and experienced authorized representatives. This established network enables efficient communication, faster query resolution, and smoother navigation through the regulatory process.
Multi-Market Registration Strategy
Planning to launch in Israel alongside the EU, US, or other markets? NexorTest develops coordinated regulatory strategies that leverage your existing documentation across multiple jurisdictions, reducing duplication of effort and optimizing your global time to market.
Transparent Timeline & Cost Management
We provide detailed project plans with clearly defined milestones, deliverables, and realistic timeline estimates before engagement. Our transparent pricing model ensures there are no hidden costs, and you receive regular progress updates throughout the registration process.
Accelerated Reference Pathway Expertise
We have extensive experience leveraging CE Marking and FDA clearances through the abbreviated pathway. Our consultants know exactly which documentation AMAR requires and how to structure submissions to minimize review cycles and avoid unnecessary delays.
Hebrew Compliance Specialists
Our Hebrew language compliance services go beyond simple translation. We employ regulatory professionals fluent in both Hebrew and English MedTech terminology who ensure that every label, instruction manual, and patient-facing document meets AMAR requirements precisely.
Full Lifecycle Regulatory Support
Our involvement extends beyond initial registration. NexorTest supports ongoing compliance including license renewals, device modifications requiring AMAR notification, post-market surveillance, vigilance reporting, and adaptation to evolving Israeli regulations such as UDI implementation and SaMD guidance.
Frequently Asked Questions
Answers to common questions about medical device registration in Israel, AMAR requirements, and the regulatory process for entering the Israeli healthcare market.
How do I register a medical device in Israel?
To register a medical device in Israel, you must submit an application to AMAR (Administration of Medical Devices, Accessories & Radiation Equipment) under the Israel Ministry of Health. The process requires appointing an Israeli Authorized Representative, classifying your device into one of four risk classes (A through D), preparing the required technical documentation, and obtaining an import license. Manufacturers holding valid CE Marking or FDA 510(k) clearance can utilize the abbreviated pathway, which significantly reduces review time by leveraging prior regulatory evaluations from these recognized reference authorities.
What is AMAR and what role does it play in Israeli medical device regulation?
AMAR stands for the Administration of Medical Devices, Accessories & Radiation Equipment. It operates under the Israel Ministry of Health and serves as the primary regulatory authority governing the import, manufacture, distribution, and marketing of medical devices in Israel. AMAR establishes device classification rules aligned with the European Union framework, evaluates registration applications for all device classes, issues import licenses that authorize commercial distribution, conducts post-market surveillance activities, and manages the vigilance system for adverse event reporting across the Israeli healthcare system.
Do I need an Israeli Authorized Representative to register a medical device?
Yes, all foreign manufacturers are legally required to appoint an Israeli Authorized Representative (AR) before submitting any device registration application to AMAR. The AR acts as the legal liaison between the manufacturer and the regulatory authority. Responsibilities include handling all official correspondence with AMAR, managing import license applications and renewals, facilitating vigilance and incident reporting, ensuring ongoing compliance with Israeli regulatory requirements, and serving as the local point of contact for any regulatory inspections or inquiries. NexorTest provides qualified AR services through our established partner network in Israel.
How long does AMAR medical device registration take?
Registration timelines depend on the device risk class and pathway chosen. Using the abbreviated pathway with an existing CE or FDA approval, typical timelines are: Class A devices take 1 to 3 months, Class B devices take 2 to 4 months, Class C devices take 3 to 6 months, and Class D devices take 4 to 8 months. For the full review pathway without reference approvals, the process generally takes 6 to 18 months or longer, depending on the complexity of the device, the completeness of the initial submission, and the volume of reviewer questions during the evaluation cycle.
Can I use my CE Marking or FDA clearance to accelerate Israel registration?
Yes, Israel recognizes CE Marking and FDA clearance through the abbreviated registration pathway. Devices holding valid CE Marking under the EU Medical Device Regulation (MDR) or the former Medical Device Directive (MDD), as well as devices with FDA 510(k) clearance or Premarket Approval (PMA), can leverage these existing approvals to substantially reduce the AMAR review timeline and documentation burden. The abbreviated pathway requires submission of the reference approval documentation alongside the AMAR application, a Free Sale Certificate, ISO 13485 certification, and the Hebrew-translated labeling package.
What are the key challenges of entering the Israeli medical device market?
Several challenges can impact manufacturers seeking to enter Israel. The mandatory Hebrew language requirement affects all labeling, instructions for use, and patient-facing documentation, requiring professional medical translation and regulatory review. The requirement to appoint and maintain a local Israeli Authorized Representative adds ongoing operational cost. The relatively small domestic market size must be weighed against the regulatory investment needed. The ongoing transition from MDD to EU MDR affects the reference approvals that AMAR accepts through the abbreviated pathway. Additionally, evolving requirements around Software as a Medical Device (SaMD) guidance, Unique Device Identification (UDI) implementation, and the shift toward digital submission processes require manufacturers to stay current with AMAR regulatory updates.
Ready to Enter the Israeli Medical Device Market?
Partner with NexorTest Technologies for expert AMAR registration consulting. Our Israel regulatory team is ready to assess your device, define the optimal pathway, and guide you through every step to a successful market launch.